Nebulized Epinephrine Dosing and Administration
For children with moderate-to-severe croup, administer nebulized epinephrine at 0.5 mL/kg of 1:1000 solution (maximum 5 mL), with effects lasting only 1-2 hours, requiring observation for at least 2-3 hours post-treatment. 1
Dosing by Weight and Indication
Children with Croup (10-30 kg)
- Standard dose: 0.5 mL/kg of 1:1000 L-epinephrine solution 1
- For a 10 kg child: 5 mL (maximum dose reached)
- For a 20 kg child: 5 mL (maximum dose)
- For a 30 kg child: 5 mL (maximum dose)
Alternative racemic epinephrine: 0.5 mL of 2.25% solution diluted in 2.5 mL normal saline, safe for all ages 2
Recent evidence demonstrates that lower doses (0.1 mg/kg) may be non-inferior to conventional doses (0.5 mg/kg) for moderate-to-severe croup, with similar efficacy and potentially fewer cardiovascular side effects 3. However, the guideline-recommended dose remains 0.5 mL/kg of 1:1000 solution.
Children Over 30 kg and Adults
For adults with upper airway obstruction: 1 mg epinephrine in 5 mL normal saline, repeated as necessary 4. This appears safe and effective with immediate benefits and minimal cardiovascular sequelae.
For bronchospasm in adults (≥4 years): 0.5 mL of 1% epinephrine solution (1-3 inhalations), not more often than every 3 hours, maximum 12 inhalations in 24 hours 5
Administration Schedule and Monitoring
Timing and Frequency
- Effect onset: Within 30 minutes, with peak effect at 30-40 minutes 3, 6
- Duration of action: 1-2 hours (short-lived) 1
- Repeat dosing: Can be repeated as necessary, but children requiring two epinephrine treatments should be hospitalized 2
- Observation period: Minimum 2-3 hours after administration before considering discharge 1
Critical Safety Considerations
Do NOT use nebulized epinephrine in children who are shortly to be discharged or on an outpatient basis 1. The transient therapeutic window necessitates careful monitoring during the latency period before corticosteroid efficacy takes effect.
Concomitant Therapy
Always administer with dexamethasone 0.6 mg/kg (or 0.15-0.6 mg/kg range) for sustained symptom control 3, 7. Epinephrine serves as a bridging intervention while awaiting corticosteroid effect.
Post-Extubation Stridor
For post-extubation stridor (Westley score ≥4): Evidence shows no dose-response relationship between 0.5 mL, 2.5 mL, and 5 mL doses 6. Higher doses (5 mL) cause significant increases in blood pressure without additional clinical benefit. Use the lowest effective dose (0.5-2.5 mL) to minimize cardiovascular side effects.
Severe Refractory Bronchospasm
For intubated patients with severe bronchospasm unresponsive to standard therapies: 0.5 mg epinephrine 1:10,000 in 10 mL normal saline administered endotracheally may provide immediate improvement when other treatments fail 8.
Common Pitfalls
- Premature discharge: The 1-2 hour effect duration means symptoms can recur after apparent improvement. Observe for at least 2-3 hours.
- Overdosing in post-extubation stridor: Higher doses provide no additional benefit and increase cardiovascular side effects 6
- Using without corticosteroids: Epinephrine alone provides only temporary relief; always combine with dexamethasone 3, 7
- Cardiovascular monitoring: Watch for tachycardia and hypertension, particularly with higher doses or repeated administration
Delivery Method Considerations
Recent simulation data shows delivery efficiency varies significantly by interface: endotracheal tubes deliver 12-32% of dose, LMAs deliver 8-15%, and face masks only 2-10% 9. This suggests intubated patients may require lower nominal doses, while face mask delivery may be less efficient than traditionally assumed.